Goldman Sachs’s Tempest Therapeutics TPST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-20,883
| Closed | -$25K | – | 5555 |
|
|
2021
Q1 | $25K | Sell |
20,883
-21,649
| -51% | -$25.9K | ﹤0.01% | 5193 |
|
|
2020
Q4 | $91K | Sell |
42,532
-37,432
| -47% | -$80.1K | ﹤0.01% | 4484 |
|
|
2020
Q3 | $130K | Sell |
79,964
-2,524
| -3% | -$4.1K | ﹤0.01% | 4173 |
|
|
2020
Q2 | $145K | Buy |
82,488
+64,097
| +349% | +$113K | ﹤0.01% | 4084 |
|
|
2020
Q1 | $97K | Buy |
+18,391
| New | +$97K | ﹤0.01% | 4173 |
|
|
2019
Q2 | – | Sell |
-14,331
| Closed | -$215K | – | 4286 |
|
|
2019
Q1 | $215K | Buy |
+14,331
| New | +$215K | ﹤0.01% | 3862 |
|
|
2018
Q1 | – | Sell |
-69,044
| Closed | -$97K | – | 4340 |
|
|
2017
Q4 | $97K | Buy |
+69,044
| New | +$97K | ﹤0.01% | 3970 |
|
|
2017
Q3 | – | Sell |
-82,383
| Closed | -$129K | – | 4408 |
|
|
2017
Q2 | $129K | Buy |
+82,383
| New | +$129K | ﹤0.01% | 4089 |
|
|
2017
Q1 | – | Sell |
-79,121
| Closed | -$121K | – | 4541 |
|
|
2016
Q4 | $121K | Buy |
79,121
+58,918
| +292% | +$90.1K | ﹤0.01% | 4051 |
|
|
2016
Q3 | $145K | Buy |
20,203
+7,957
| +65% | +$57.1K | ﹤0.01% | 4059 |
|
|
2016
Q2 | $64K | Sell |
12,246
-18,760
| -61% | -$98K | ﹤0.01% | 4222 |
|
|
2016
Q1 | $294K | Sell |
31,006
-325,533
| -91% | -$3.09M | ﹤0.01% | 3559 |
|
|
2015
Q4 | $3.48M | Buy |
356,539
+280,796
| +371% | +$2.74M | ﹤0.01% | 2242 |
|
|
2015
Q3 | $643K | Buy |
75,743
+49,413
| +188% | +$419K | ﹤0.01% | 3157 |
|
|
2015
Q2 | $762K | Buy |
26,330
+13,781
| +110% | +$399K | ﹤0.01% | 3092 |
|
|
2015
Q1 | $436K | Buy |
12,549
+6,659
| +113% | +$231K | ﹤0.01% | 3402 |
|
|
2014
Q4 | $260K | Buy |
+5,890
| New | +$260K | ﹤0.01% | 3800 |
|